In This Section
Investor Relations
Get stock updates, FAQs, and more.
Our Best-in-Class Companies
Find a powerful partner that promises results.
Contact Information
If you are representing a media outlet and have immediate questions, please contact:
MARCIA FREDERICK
614.543.6281
mfrederick@inventivhealth.com
Press Releases
inVentiv Health Selected by Forbes Magazine Among its 200 Best Small Companies
Most Recent Ranking Follows Recognition on Lists Compiled by Fortune and BusinessWeek
SOMERSET, N.J., Oct. 20 -- inVentiv Health, Inc. (Nasdaq: VTIV - News) was selected as one of Forbes Magazine's America's 200 Best Small Companies, ranking #84 among the nation's top 200 small companies on the list. The list of the 200 small companies appears in the October 30, 2006 issue of Forbes Magazine and is available online at http://www.forbes.com.
"We are delighted to be recognized, yet again, for the accomplishments we have achieved and to be included in the Best Small Companies list compiled by Forbes Magazine," said Eran Broshy, Chairman and Chief Executive Officer of inVentiv Health. "Our goal continues to be focused on providing our pharmaceutical and biotech clients with a broad range of unique solutions to address their needs. Our accomplishments have translated into strong growth, with total revenues growing at a compound annual rate of 37% from 2002 to 2005 and 41% for the first half of 2006 over the 2005 comparable period. Our business success has resulted in value for shareholders and we are focused on continuing this pattern of growth going forward."
According to Forbes, the list of the 200 Best Small Companies ferrets out the most robust, fundamentally disciplined public outfits with sales between $5 million and $750 million. To qualify, a company must have had a share price above $5 as of September 29, 2006 on three-month average volume of 10,000 or more shares. Candidates must also carry profit margins of greater than 5%, with positive sales and profit growth, on average, over both the last five years and last 12 months.
In addition to the Forbes ranking, inVentiv was also recently ranked as one of FORTUNE Magazine's Top 100 Fastest Growing Companies as well as BusinessWeek's "Hot Growth 100" companies for 2006.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: our ability to sufficiently increase our revenues and maintain or decrease expenses and cash capital expenditures to permit us to fund our operations; our ability to continue to comply with the covenants and terms of our credit facility and to access sufficient capital to fund our operations; our ability to grow our existing client relationships, obtain new clients and cross-sell our services; our ability to successfully operate new lines of business; our ability to manage our infrastructure and resources to support our growth; our ability to successfully identify new businesses to acquire, conclude acquisition negotiations and integrate the acquired businesses into our operations; any disruptions, impairments, or malfunctions affecting software as well as excessive costs or delays that may adversely impact our continued investment in and development of software; the potential impact of government regulation on us and on our clients base; our ability to comply with all applicable laws as well as our ability to successfully implement from a timing and cost perspective any changes in applicable laws; our ability to recruit, motivate and retain qualified personnel, including sales representatives; the actual impact of the adoption of certain accounting standards; our ability to maintain technological advantages in a variety of functional areas, including sales force automation, electronic claims surveillance and patient compliance; changes in trends in the healthcare and pharmaceutical industries or in pharmaceutical outsourcing; and our inability to determine the actual time at which the liquidation of the Columbia Strategic Cash Portfolio will be completed or the total losses that we will actually realize from that investment vehicle. . Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
